05.01.18
ISRAEL: Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health, Ltd., New Zealand, to supply China and Asia-Pacific with astaxanthin and other algae-based products.
Supreme Health identified and cultivated a unique strain of the microalgae Haematococcus pluvialis in Nelson Lakes, northern New Zealand, for the production of natural astaxanthin. Algatech, a global leader in the microalgae industry, will provide its know-how, innovative science and advanced microalgae cultivation technologies to leverage the capabilities of the New Zealand-based company.
Supreme, led by CEO Kerry Paul, enjoys strong recognition for its natural astaxanthin, and its cutting-edge science. The company, with well-established marketing channels in China, New Zealand and Australia, will focus on marketing microalgae ingredients and astaxanthin-based products to food, dietary supplement and cosmetic industries throughout Asia-Pacific, with special emphasis on China.
Supreme Health identified and cultivated a unique strain of the microalgae Haematococcus pluvialis in Nelson Lakes, northern New Zealand, for the production of natural astaxanthin. Algatech, a global leader in the microalgae industry, will provide its know-how, innovative science and advanced microalgae cultivation technologies to leverage the capabilities of the New Zealand-based company.
Supreme, led by CEO Kerry Paul, enjoys strong recognition for its natural astaxanthin, and its cutting-edge science. The company, with well-established marketing channels in China, New Zealand and Australia, will focus on marketing microalgae ingredients and astaxanthin-based products to food, dietary supplement and cosmetic industries throughout Asia-Pacific, with special emphasis on China.